![](/img/cover-not-exists.png)
LBA-005KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer
Shitara, K, Özgüroğlu, M, Bang, Y J, Di Bartolomeo, M, Mandalà, M, Ryu, M H, Fornaro, L, Olesiński, T, Caglevic, C, Chung, H, Muro, K, Gökkurt, E, Mansoor, W, McDermott, R, Schacham-Shmueli, E, Chen,Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy208.004
Date:
June, 2018
File:
PDF, 47 KB
english, 2018